Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration

Pre-existing anti-adenovirus (Ad) neutralizing antibodies (AdNAbs) are a major barrier in clinical gene therapy using Ad vectors and oncolytic Ads; however, it has not been fully elucidated which Ad capsid protein-specific antibodies are involved in AdNAb-mediated inhibition of Ad infection in vivo....

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Kyoko, Sakurai, Fuminori, Iizuka, Shunsuke, Hemmi, Masahisa, Wakabayashi, Keisaku, Machitani, Mitsuhiro, Tachibana, Masashi, Katayama, Kazufumi, Kamada, Haruhiko, Mizuguchi, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098129/
https://www.ncbi.nlm.nih.gov/pubmed/30120324
http://dx.doi.org/10.1038/s41598-018-30947-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098129/
https://www.ncbi.nlm.nih.gov/pubmed/30120324
http://dx.doi.org/10.1038/s41598-018-30947-z

Ejemplares similares